Dongbang Medical Co., Ltd (KOSDAQ:240550)

Market Cap	135.23B -37.9%
Revenue (ttm)	117.37B +8.2%
Net Income	13.94B +275.2%
EPS	657.22 +205.5%
Shares Out	20.93M
PE Ratio	9.83
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	76,100
Open	6,460.00
Previous Close	6,460.00
Day's Range	6,370.00 - 6,800.00
52-Week Range	6,250.00 - 15,130.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 3, 2026

About Dongbang Medical

Dongbang Medical Co., Ltd produces and sells medical devices, fillers, bio medical devices, and cosmetics devices in South Korea. It offers HA filler, a medical device used for improving facial wrinkles and volume recovery under the ELASTY GRAND, ELASTY DEEP PLUS, ELASTY G PLUS, ELASTY D PLUS, and ELASTY F PLUS names; threads under the ELASTY LINE, ELASTY MESHFILL, ELASTY-V BARB, ELASTY-V UP, ELASTY-V SCREW, and ELASTY-V MONO names; and cannula, needle, and syringe products. The company also provides Hyaluronic acid mask, Beta-Glucan mask, FILL...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1985
• Employees: 282
• Stock Exchange: KOSDAQ
• Ticker Symbol: 240550

Financial Performance

In 2025, Dongbang Medical's revenue was 113.54 billion, an increase of 8.01% compared to the previous year's 105.11 billion. Earnings were 11.70 billion, an increase of 301.58%.